Express Scripts drops Amgen anemia drugs from formulary

August 1, 2014 11:01 PM

16 0

(Reuters) - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen and Aranesp, both sold by Amgen Inc.

The company will continue to include Procrit, a similar anemia drug sold by Johnson & Johnson, on its list of preferred drugs, or formulary.

Read more

To category page